Clinical Trial Update: Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC [Phase 2]

View source ↗

Summary

Phase II study evaluating first-line pemetrexed (Alimta) + gemcitabine (Gemzar) + bevacizumab (Avastin) in elderly patients with Stage IIIB/IV Non-Small Cell Lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Avastin (bevacizumab)
• Gemzar (gemcitabine)

Snippet

Sponsor: Accelerated Community Oncology Research Network | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-03-08